search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
TESTING


a quantitative indication of a product’s irritation potential. A longer time for the product to reduce tissue viability by 50% suggests a milder product, while a shorter time indicates a higher irritation potential. The viability itself is measured by MTT


assay. This assay is also used in the OECD TG 492 and is, thus, a good known colorimetric method for assessing cell vitality and viability. It measures cellular metabolic activity by converting the yellow tetrazolium salt (MTT) into purple formazan crystals in viable cells. The intensity of the purple colour, quantified using a spectrophotometer, correlates with the number of metabolically active cells.15 Figure 2 shows the samples of different shampoos for adults, children and babies as well as the positive and negative controls after different incubation periods. The clear colouring shows that baby shampoos are noticeably milder than shampoo for adults. This clear, measurable approach helps


manufacturers assess how products will perform in real-world applications, especially for those designed for use around the eyes, where even slight irritation can lead to discomfort. The result gives a statement within the irritation classification of minimal/ non-irritating, mild, moderate and severe. In comparison to the results of OECD


TG 492, which is concerned with whether or not a product causes moderate or severe irritation, the ‘No Tears’ test design considers exactly the other half of the scale, and products can be categorised as non-/minimally irritating or mild, or are assessed as irritating (moderate and severe). That means, while the OECD TG 492 categorize a product as non-irritating by excluding damages to the eye, the ‘No Tears’ test design cares about categorizing the non- irritating products according to their mildness. As a result, the ‘No Tears’ test design offers


the possibility of specifically labelling mild and non-/minimally irritating cosmetics. To even generate a possibility to provide end consumers this valuable information, Dermatest has developed the ‘No Tears’ seal for cosmetic manufacturers as a possible labelling option if the test is passed (Figure 3). Dermatest‘s ‘No Tears’ test design and seal,


thus, closes the gap that currently exists and offers a method and tool for valid and reliable labelling of cosmetics and their effect on the eyes.


This gap becomes particularly apparent when the ‘No Tears’ test design is not only directly compared to OECD TG 492 but also to the other previously mentioned methods. This comparison clearly shows that the ‘No Tears’ test design offers many advantages that the other methods can only partially cover. Table 2 summarises the essential evaluation


criteria and results for Dermatest that led to the decision to establish ‘No Tears’ test and not one of the other methods. Even though some of the other methods fulfil some of the criteria, ‘No Tears’ test is the only method that fulfils all criteria with ‘Very good’ and meets Dermatest’s own high scientific quality standards. Thus, unlike traditional methods whose reproducibility is, mainly due to a lack of


www.personalcaremagazine.com


109


serums. This customization helps ensure that the test accurately reflects how the product will behave in real-world conditions. By adapting the test design to suit different types of products, Dermatest ensures that manufacturers receive the most accurate and meaningful data possible.


Figure 3: Dermatest ‘No Tears’ Seal provided for cosmetic manufacturers as a labeling option if their products can be classified as mild or extra mild


objective data, questionable, Dermatest’s ‘No Tears’ test design provides highly reproducible and quantitative data. This allows companies to make precise formulation adjustments and better compare products. This is especially important for manufacturers who wish to offer products that cater to consumers with sensitive eyes.


The ‘No Tears’ test also complies with


all ethical requirements. By eliminating the need for animal testing, animal derived test models or human trials, the ‘No Tears’ test aligns with global ethical standards and caters to the growing demand for cruelty-free products. It ensures that companies can meet consumer expectations for safety and ethical responsibility. One of the notable strengths of the ‘No


Tears’ test is that it uses tailored exposure models that guarantee the high flexibility of the test design. The test can be customized based on the specific characteristics of the product being tested, ensuring that the exposure models are realistic and relevant. For instance, products containing


surfactants, such as shampoos and facial cleansers, are tested differently from non- surfactant-based products like eye creams or


Conclusion and future directions Sensitivity is a growing concern for many consumers, and the cosmetic industry plays a significant role in either exacerbating or alleviating this issue. The development of testing methods that can accurately assess the irritation potential of products, particularly those designed for use around the eyes, is crucial to ensuring safety and comfort for consumers. The ‘No Tears’ test design established by


Dermatest represents a significant step forward in this regard, offering a more precise, objective and ethical approach to assess the safety of cosmetic products for eyes. By providing quantitative, reliable, and ethically sound data, this testing method helps ensure that products are both safe and effective, giving consumers the peace of mind they need when selecting products for their delicate eye areas. The importance of a tailored test design for


identification of mild and extra mild products becomes even more clear when we consider cosmetic cleansing products. In contrast to products such as eye serums or day creams, that are normally used by adults and where a misleading declaration of the product can cause a temporary discomfort in persons with sensitive eyes, certain cleansing products are regularly also used by babies and small children. However, babies and small children are very


sensitive by nature as their eyes have fewer natural defences to cope with external stressors. Using surfactant-containing products that are not suitable for sensitive eyes can, thus, not only lead to temporary problems like in adults but may lead to long-term damage especially when they get exposed to it regularly.


April 2025 PERSONAL CARE


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132